Cancer Research

The evening ritual of uncorking a bottle of wine or cracking open a cold beer often serves as a symbolic bridge between the pressures of the workday and the sanctuary of home life. This habit, deeply ingrained in social fabric, is frequently perceived as a harmless or even beneficial component of a

The landscape of metastatic prostate cancer treatment is shifting toward aggressive early intervention as long-term data now prove that hitting the disease with everything available at the start significantly extends life expectancy. For years, clinicians grappled with the dilemma of whether to

The success of the world’s first personalized mRNA cancer vaccine provides a critical proof of concept that could eventually be applied to various other types of malignancies. This medical milestone, recently unveiled at the European Society for Medical Oncology Congress 2026, represents a

Dr. Hans-Peter Kiem’s early medical training at the University of Ulm laid the groundwork for his future breakthroughs in the regenerative potential of hematopoietic stem cells. This fascination with the building blocks of the blood system eventually propelled him to the forefront of translational

Novo Nordisk now trades at roughly 14 times earnings, representing a significant discount compared to its primary rival, Eli Lilly, which commands a multiple of 34 times earnings. This stark valuation gap emerges at a time when the broader financial landscape appears increasingly disconnected from

A lack of standardized data elements across different tumor types makes it difficult for researchers to track patient outcomes over long periods. This fundamental challenge often forces life sciences companies to rely on fragmented information that fails to capture the true complexity of a